Home
Live Updates
CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates : vimarsana.com
CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates
SUZHOU, China, March 27, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research,
Related Keywords
China ,
United States ,
Thailand ,
United Kingdom ,
Singapore ,
London ,
City Of ,
Taiwan ,
Australia ,
Macau ,
Hong Kong ,
Suzhou ,
Jiangsu ,
Australian ,
American ,
British ,
Chinese ,
America ,
Les Laboratoires Servier ,
Jason Yang ,
National Medical Products Administration ,
Pfizer ,
Esmo Gi Congress ,
Chinese Medical Association ,
Cstone Pharmaceuticals ,
Research Pipeline Leveraging Multiple Sources Of Innovation ,
Chinese Society Of Clinical Oncology ,
International Financial Reporting Standards ,
Clinical Cancer Research ,
3sbio Inc ,
Blueprint Medicines Corporation ,
European Medicines Agency ,
Australian Human Research Ethics Committee ,
Jiangsu Hengrui Pharmaceuticals Co Ltd ,
Drug Administration ,
Data Monitoring Committee ,
European Union ,
European Society For Medical Oncology ,
American Society Of Clinical Oncology ,
Committee For Medicinal Products Human Use ,
Allist Pharmaceuticals ,
Regulatory Agency ,
Pipeline Development ,
Contract Research Organization ,
American Society Of Hematology Annual Meeting ,
Cancer Association ,
Good Clinical Practice ,
Mainland China ,
American Society ,
Clinical Oncology ,
Annual Meeting ,
European Society ,
Medical Oncology ,
Gastrointestinal Cancer ,
Nature Medicine ,
Nature Cancer ,
Greater China ,
Drug Evaluation ,
Maximizing Commercial Value ,
National Reimbursement Drug List ,
National Basic Medical Insurance ,
Work Related Injury Insurance ,
Maternity Insurance ,
Systemic Mastocytosis ,
Anti Cancer Association ,
Hematological Oncology Guideline ,
Medical Association ,
Hematology Annual Meeting ,
Further Information ,
Outstanding Issues ,
Overall Survival ,
Combined Positive Score ,
British Journal ,
Taiwan Food ,
Blueprint Medicines ,
Clinical Cancer ,
Research Pipeline Leveraging Multiple Sources ,
License Agreement ,
Medicinal Products ,
Human Use ,
Financial Reporting Standards ,
Pharmaceuticals Reports ,
Thailand Business ,
vimarsana.com © 2020. All Rights Reserved.